Branched-chain amino acid-enriched diet: Effects on insulin secretion and cellular immune aggression

Proceedings of the Society for Experimental Biology and Medicine

Volumn 224, Issue 3, 2000, Pages 159-165

  Karabatas, L M ^a   Fabiano De Bruno, L ^a   Pastorale, C ^a   Lombardo, Y B ^b   Basabe, J C ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BRANCHED CHAIN AMINO ACID; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HORMONE INHIBITION; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PROTEIN DIET; SPLEEN CELL;

EID: 0033949312     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22415.x     Document Type: Article

References (42)

1. Castaño L, Eisenbarth G. Type I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679, 1990.
2. Scott FW, Elliott RB, Kolb H. Diet and autoimmunity: Prospects of prevention of Type I diabetes. Diabetes Nutr Metab 2:61-73, 1989.
3. Riccardi G, Rivellese AA. Can diabetes mellitus be prevented by diet? Diabetes Nutr Metab 2:259-262, 1989.
4. Scott FW. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev 12:341-359, 1996.
5. Scott FW, Cloutier HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: Dose, timing, early effects on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes 46:589-598, 1997.
6. Siegel EG, Trapp VE, Wollheim CB, Renold AE, Schmidt FH. Beneficial effects of low-carbohydrate-high-protein diets in long-term diabetic rats. Metabolism 29:421-428, 1980.
7. Eizirik DL, Migliorini RH. Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein, carbohydrate-free diet. Diabetes 33:383-388, 1984.
8. Eizirik DL, Tze WJ, Tai J, Migliorini RH. Effects of a high-protein diet on the evolution of diabetes in streptozotocin-induced and spontaneously diabetic BB Wistar rats. Acta Diabetol Lat 23:107-116, 1986.
9. Karabatas LM, Lombardo YB, Basabe JC. High-protein diet: Effect on insulin secretion patterns from streptozotocin-diabetic rats and mice. Acta Physiol Pharmacol Ther Latinoam 42:239-254, 1993.
10. Karabatas LM, Lombardo Y, Basabe JC. Effect of high-protein feeding on insulin secretion in mice injected with splenocytes from diabetic mice. Proc Soc Exp Biol Med 211:81-86, 1996.
11. Reyes AA, Klahr S. Dietary supplementation of L-arginine ameliorates renal hypertrophy in rats fed a high-protein diet. Proc Soc Exp Biol Med 206:157-161, 1994.
12. Eisenstein AB, Strack I, Galo-Torres H, Georgiadis A, Miller ON. Increased glucagon secretion in protein-fed rats: Lack of relationship to plasma amino acids. Am J Physiol 236:E20-E27, 1979.
13. Eizirik DL, Kettelhut IC, Migliorini RH. Administration of branched-chain amino acids reduces the diabetogenic effect of streptozotocin in rats. Braz J Med Biol Res 20:137-144, 1987.
14. Boitard C, Debray-Sachs M, Plouplard A, Assan R, Hamburger J. Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia 21:41-46, 1981.
15. Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC. Cellular and humoural autoimmunity markers in Type 2 (noninsulin-dependent) diabetic patients with secondary drug failure. Diabetologia 35:1159-1164, 1992.
16. Eizirik DL, Germano CM, Migliorini RH. Dietetic supplementation with branched-chain amino acids attenuates the severity of streptozotocin-induced diabetes in rats. Acta Diabetol Lat 25:117-126, 1988.
17. Bieri JG. Second report of the ad hoc Committee on Standards for Nutritional Studies. J Nutr 110:1726, 1980.
18. Buschard K, Rygaard J. Passive transfer of streptozotocin-induced diabetes mellitus with spleen cells. Acta Pathol Microbiol Scand (C) 85:469-472, 1977.
19. Arata M, Fabiano de Bruno L, Goncalvez Volpini W, Quintans JC, D'Alessandro VG, Braun M, Basabe JC. β-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice. Proc Soc Exp Biol Med 206:76-82, 1994.
20. Phillips HJ. Dye exclusion test for cell viability. In: Kruse G, Patterson C, Eds. Tissue: Methods and Applications. New York: Academic Press, pp406-408, 1973.
21. Burr IM, Stauffacher W, Balant L, Renold AE, Grodsky G. Dynamic aspects of proinsulin release from perifused rat pancreas. Lancet 2:882-883, 1969.
22. Basabe JC, Karabatas LM, Arata M, Pivetta OH, Cresto JC. Secretion and effect of somatostatin in early stages of the diabetic syndrome in C57BL/KsJ mdb mice. Diabetologia 29:485-488, 1986.
23. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967.
24. Ono J, Takaki R, Fukuma M. Preparation of single cells from pancreatic islets, of adult rats by the use of dispase. Endocrinol Jpn 24:265-270, 1977.
25. Herbert V, Lau K, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965.
26. Eizirik DL, Sandler S. The partial protective effect of branched chain amino acids against streptozotocin-induced cytotoxicity to mouse pancreatic islets in vitro. Pharmacol Toxicol 61:320-324, 1987.
27. Scott FW, Mongeau R, Kardish M, Hatina G, Trick KD, Wojcinski Z. Diet can prevent diabetes in the BB rat. Diabetes 34:1059-1062, 1985.
28. Harper AE, Benevenga NJ, Wohlueter RM. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev 50:428-558, 1970.
29. National Research Council. Nutrient requirements of the mouse. In: National Research Council, Ed. Nutrient Requirements of Laboratory Animals (3rd ed). Washington, DC: National Academy of Sciences, pp38-53, 1978.
30. Arata M, Fabiano de Bruno L, Goncalvez Volpini W, Gagliardi G, Quintans CJ, Basabe JC. Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients. Metabolism 44:1435-1441, 1995.
31. Karabatas LM, Fabiano de Bruno L, Pastorale CF, Cullen C, Basabe JC. Inhibition of nitric oxide generation: Normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors. Metabolism 45:940-946, 1996.
32. Boitard C, Chatenoud L, Debray-Sach N. In vitro inhibition of pancreatic β cell function by lymphocytes from diabetics with associated autoimmune diseases: A T-cell phenomenon. J Immunol 129:2529-2531, 1982.
33. Lang F, Maugendre D, Houssaint E, Charbonnel B, Sai P. Cytoadherence of lymphocytes from type I diabetic subjects to insulin-secreting cells: Marker of anti-β-cell cellular immunity. Diabetes 36:1356-1364, 1987.
34. Segain JP, Valentin A, Bardet S, Feve B, Sevestre H, Houssaint E, Charbonnel B, Sai P. In vitro relationship of CD4 cells from type I diabetic patients and xenogeneic β-cell membranes. Diabetes 38:634-640, 1989.
35. Aschkenasy A. Differing effects of dietary protein deprivation on the production of rosette-forming cells in the lymph nodes and the spleen and on the level of serum hemagglutinin in rats immunized to sheep red blood cells. Immunology 24:617-633, 1973.
36. Kuhlman G, Roth JA, Flakoll PJ, Vandehaar MJ, Nissen S. Effects of dietary leucine, α-ketoisocaproate and isovalerate on antibody production and lymphocyte blastogenesis in growing lambs. J Nutr 118:1564-1569, 1988.
37. Utsugi T, Kanda T, Tagima Y, Kato N, Tomondo S, Suzuki T, Kawazu S, Murata K. Branched chain amino acids suppress the diabetogenicity of a new variant of EMC virus. Diabetes 40(Suppl 1):216A, 1991.
38. Elliott RB, Reddy SN, Bibby NJ, Kida K. Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 31:992-998, 1994.
39. Li XB, Scott FW, Park YH, Yoon JW. Low incidence of autoimmune type I diabetes in BB rats fed a hydrolised casein-based diet associated with early inhibition of non-macrophage-dependent hyperexpression of MHC class I molecules on β cells. Diabetologia 38:1138-1147, 1995.
40. Schafer G, Schatz H. Long-term effects of leucine and arginine on B-cell function of cultivated pancreatic islets. J Endocrinol 91:255-262, 1981.
41. Ammon HPT, Hoppe E, Akhtar MS, Niklas H. Effect of leucine on the pyridine nucleotide contents of islets and on the insulin release: Interactions in vitro with methylene blue, thiol oxidants, and p-chloromercuribenzoate. Diabetes 28:593-599, 1979.
42. Madsen DC. Branched-chain amino acids: Metabolic roles and clinical application. In: Johnston JDA, Ed. Advances in Clinical Nutrition: Proceedings of the 2nd International Symposium. Boston: MTP Press Limited, pp3-23, 1982.